CD80 and neoplasm: Almost complete inhibition of anti-CD3/B7.1-stimulated T cell proliferation occurred when co-cultured with peritoneal macrophages (CD11b+F4/80+) isolated from MOSEC-ID8 mice at day 90 after tumor challenge (Fig. 1h).